What is the biggest risk of taking both together
When food reaches the small intestine, it triggers the release of GLP-1, leading to a feeling of fullness, and stimulates the release of insulin, which lowers blood sugar
Compounded tirzepatide typically costs $150 to $500 per month depending on the dose, pharmacy, and formulation
Muscle wasting in the context of T2D and obesity represents not only a complication but also a driver of disease progression, contributing to diminished insulin sensitivity, reduced physical capacity and adverse outcomes [3]
A 2014 review of 15 scientific studies found that a combination of GLP-1 medication and insulin provided better glycemic control than other treatment regimens (including insulin alone)
Generally, newer medications, such as GLP-1 agonists, are the least likely to be covered, while older drugs are commonly found on formularies